See more : Europa Metals Limited (EUZ.L) Income Statement Analysis – Financial Results
Complete financial analysis of Rising BioSciences, Inc. (RBII) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Rising BioSciences, Inc., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Array Technologies, Inc. (ARRY) Income Statement Analysis – Financial Results
- GSL Securities Limited (GSLSEC.BO) Income Statement Analysis – Financial Results
- Methanex Corporation (MEOH) Income Statement Analysis – Financial Results
- Murapol S.A. (MUR.WA) Income Statement Analysis – Financial Results
- Live Verdure Ltd (LV1.AX) Income Statement Analysis – Financial Results
Rising BioSciences, Inc. (RBII)
Industry: Medical - Pharmaceuticals
Sector: Healthcare
About Rising BioSciences, Inc.
Rising BioSciences, Inc. develops and manufactures topical and oral pharmaceutical products, including medical marijuana products. The company is based in Sheridan, Wyoming.
| Metric | 2020 | 2019 |
|---|---|---|
| Revenue | 782.28K | 163.73K |
| Cost of Revenue | 333.90K | 232.67K |
| Gross Profit | 448.38K | -68.94K |
| Gross Profit Ratio | 57.32% | -42.10% |
| Research & Development | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 |
| SG&A | 164.21K | 110.32K |
| Other Expenses | 0.00 | 0.00 |
| Operating Expenses | 164.21K | 110.32K |
| Cost & Expenses | 498.11K | 343.00K |
| Interest Income | 0.00 | 0.00 |
| Interest Expense | 69.41K | 73.82K |
| Depreciation & Amortization | 33.52K | 33.52K |
| EBITDA | 152.69K | -145.74K |
| EBITDA Ratio | 19.52% | -89.01% |
| Operating Income | 284.17K | -179.26K |
| Operating Income Ratio | 36.33% | -109.48% |
| Total Other Income/Expenses | -234.41K | -73.97K |
| Income Before Tax | 49.76K | -253.23K |
| Income Before Tax Ratio | 6.36% | -154.66% |
| Income Tax Expense | 3.00 | 151.00 |
| Net Income | 49.76K | -253.23K |
| Net Income Ratio | 6.36% | -154.66% |
| EPS | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 |
| Weighted Avg Shares Out | 1.06B | 843.73M |
| Weighted Avg Shares Out (Dil) | 1.06B | 843.73M |
No news found for: RBII
Source: https://incomestatements.info
Category: Stock Reports